FDAnews Device Daily Bulletin

Law Expert Says High Court Likely to Favor Prometheus Test Patent

Dec. 14, 2011
The U.S. Supreme Court appears unconvinced after oral arguments on Prometheus Laboratories’ thiopurine metabolites test patent, but one legal expert predicts the high court will uphold an appeals court decision in favor of Prometheus.
Devices & Diagnostics Letter